| Literature DB >> 26109886 |
Rupal A Vasant1, A V R L Narasimhacharya2.
Abstract
Consumption of fluoride leads to several physiological disturbances in carbohydrate, lipid and antioxidant metabolisms. Averrhoa carambola L. fruit (Star fruit) is a commonly consumed fruit in tropical countries and is an ingredient in folklore medicines. As the fruits have high polyphenolic and antioxidant contents, the present study was undertaken to investigate the potential of star fruit as a dietary supplement in attenuating the fluoride induced hyperglycemia, hypercholesterolemia and oxidative stress in laboratory rats. A four-week exposure to fluoride caused sustained hyperglycemia, hyperlipidemia and oxidative stress and, when the diet was supplemented with star fruit powder, carbohydrate, lipid and antioxidant profiles were restored significantly. It is surmised that the antihyperglycemic, antihypercholesterolemic and antioxidant activities of star fruit in fluoride exposed rats could be due to the presence of polyphenols, flavonoids, saponins, phytosterols, ascorbic acid and fibers in the fruit, which are all well known regulators of carbohydrate, lipid and antioxidant metabolisms. These findings suggest that star fruit can be used as a dietary supplement in fluoride endemic regions to contain fluoride induced hyperglycemia, hyperlipidemia and oxidative stress.Entities:
Keywords: carbohydrate metabolism; fluoride; lipid metabolism; oxidative stress; star fruit
Year: 2014 PMID: 26109886 PMCID: PMC4427722 DOI: 10.2478/intox-2014-0014
Source DB: PubMed Journal: Interdiscip Toxicol ISSN: 1337-6853
Figure 1Food intake, body and liver weights. Values are mean ± SEM (n=6); a - compared with NC, b - compared with FC group
Figure 2Plasma glucose and hepatic carbohydrate profiles. Values are mean ± SEM (n=6); a - compared with NC, b - compared with FC group
Figure 3Serum enzymatic profiles. Values are mean ± SEM (n=6); a - compared with NC, b - compared with FC group
Effect of A. carambola plasma total lipids, atherogenic index, Hepatic HMG-CoA and FRAP values.
| Parameters | NC | FC | F Ac I | F Ac II | F Ac III |
|---|---|---|---|---|---|
|
| 317.37±0.76 | 470.17±0.63 | 445.60±1.08 | 390.31±1.81 | 347.77±0.81 |
|
| 1.58±0.01 | 3.33±0.03 | 3.04±0.02 | 2.31±0.02 | 1.65±0.01 |
| HMG-CoA reductase | 3.87±0.02 | 8.10±0.86 | 7.68±0.14 | 6.93±0.10 | 4.98±0.45 |
|
| 286.12±0.35 | 159.49±0.33 | 195.67±0.38 | 219.96±0.20 | 246.46±0.38 |
Values are represented as mean ± SEM (n=6).
Indicates the comparison with normal control group
Denotes the comparison with fluoride control group at p<0.05; Percent changes (figures in parenthesis) in fluoride control group were in comparison with normal control and in those treatment groups were in comparison with fluoride control group
HMG-CoA reductase activity is inversely proportional to the ratio of HMG-CoA/ mevalonate.
Figure 4Plasma lipid profiles. Values are mean ± SEM (n=6); a - compared with NC, b - compared with FC group
Figure 5Hepatic and fecal lipid profiles. Values are mean ± SEM (n=6); a - compared with NC, b - compared with FC group
Figure 6Hepatic and renal lipid peroxidation and non-enzymatic antioxidants. Values are mean ± SEM (n=6); a - compared with NC, b - compared with FC group.
Figure 7Hepatic and renal enzymatic antioxidants. Values are mean ± SEM (n=6); a - compared with NC, b - compared with FC group.